FDA approves third COVID-19 antibody treatment for emergency use
Tdap vaccination tied to lower dementia risk in older adults
28 May 2021Providing more low-value care doesn’t lead to higher patient experience ratings
28 May 2021FDA approves third COVID-19 antibody treatment for emergency use
A third antibody treatment designed to keep high-risk COVID-19 patients from being hospitalized was approved for emergency use by the U.S. Food and Drug Administration on Wednesday.
